View in EDS HTML Full Text PDF Full Text

The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation.

Saved in:
Bibliographic Details
Title: The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation.
Authors: Smith, Katie J.1 (AUTHOR), Minns, Danielle1 (AUTHOR), McHugh, Brian J.1 (AUTHOR), Holloway, Rebecca K.2,3 (AUTHOR), O'Connor, Richard1 (AUTHOR), Williams, Anna4 (AUTHOR), Melrose, Lauren1 (AUTHOR), McPherson, Rhoanne1 (AUTHOR), Miron, Veronique E.2 (AUTHOR), Davidson, Donald J.1 (AUTHOR), Gwyer Findlay, Emily1 (AUTHOR) Emily.findlay@ed.ac.uk
Source: PLoS Biology. 8/26/2022, Vol. 20 Issue 8, p1-27. 27p. 7 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15449173
DOI:10.1371/journal.pbio.3001554